COMMUNIQUÉS West-GlobeNewswire

Innovations with Ed Begley Jr. to Feature Canada House’s Evidence-Based Cannabis Products & Services on Fox Business Innovations TV Series

09/03/2018 - 14:32

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is [...]

Galectin Therapeutics to Present at Two International Conferences in March

09/03/2018 - 14:30

NORCROSS, Ga., March 09, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’ [...]

EyeGate Pharma To Participate At The 30TH Annual ROTH Conference

09/03/2018 - 14:30

WALTHAM, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]

First Choice Healthcare Solutions Announces Appointment of Sheila Schweitzer to Board of Directors and Retirement of Donald Bittar

09/03/2018 - 14:30

MELBOURNE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare [...]

Scythian Biosciences Corp. Announces Results of Special Meeting of Shareholders and Grant of Options and DSUs

09/03/2018 - 14:25

TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) is pleased to announce the results of its special [...]

Teladoc to Participate in Upcoming Investor Conferences

09/03/2018 - 14:21

PURCHASE, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that Mark Hirschhorn, chief operating [...]

Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies

09/03/2018 - 14:00

SAN DIEGO, March 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Aclaris Therapeutics Announces Issuance of U.S. Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders

09/03/2018 - 14:00

Issuance of U.S. Patent No. 9,895,301 Further Bolsters Aclaris’ Intellectual Patent Portfolio WAYNE, Pa., March 09, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, [...]

Vericel to Present at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference

09/03/2018 - 14:00

CAMBRIDGE, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Gerard Michel, [...]

Exalenz Bioscience to Participate in Upcoming Investor Conferences

09/03/2018 - 14:00

MODI’IN, Israel and MANASQUAN, N.J., March 09, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN ), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]

Stealth Mark Joins the Industry Council for Tangible Assets and its Anti-Counterfeiting Task Force

09/03/2018 - 14:00

HOFFMAN ESTATES, IL , March 09, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI ) is pleased to announce that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, has joined the Industry [...]

Arch Biopartners Closes $1.25M Non-Brokered Private Placement Financing

09/03/2018 - 14:00

TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) and (OTCBB: ACHFF ), announced today it has closed the non-brokered private placement the Company disclosed in [...]

VBL Therapeutics to Report Fiscal 2017 Results on March 15

09/03/2018 - 14:00

TEL AVIV, Israel, March 09, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

09/03/2018 - 13:30

DUBLIN, Ireland, March 09, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq AVDL), “Avadel” or “the Company,” today announced that management will present at two upcoming investor conferences: The 30 th [...]

Projecting a Per Share Price Target of $1.25, PotNetwork Holding Inc. Highlighted as “Strong Speculative Buy” in Research Initiated by Harbinger Research, LLC

09/03/2018 - 13:27

FT LAUDERDALE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holding, Inc. (OTC Pink:POTN ) (“Company”) is pleased to announce today that PotNetwork the Company and Diamond CBD have been the [...]

Orphazyme to Present at Cowen & Co. 38th Annual Health Care Conference

09/03/2018 - 13:23

Orphazyme A/S Investor news No. 04/2018 Copenhagen, March 9, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders [...]

Sonoma Pharmaceuticals to Present at Roth Capital Partners 30th Annual Growth Stock Conference on March 13, 2018

09/03/2018 - 13:05

PETALUMA, Calif., March 09, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA, Warrants – SNOAW) today announced that Jim Schutz, Sonoma CEO, will be a featured presenter at the Roth Capital Partners [...]

Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease

09/03/2018 - 13:02

Robust and durable improvements in patients' motor function achieved with substantial reductions in use of daily oral levodopa and other Parkinson’s disease medications; one-time administrations of VY-AADC well- [...]

ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

09/03/2018 - 13:01

Pipeline Achievements in 2017 Included Progress with Three Phase 3 and Two Phase 2 Clinical Trials -Key 2018 Clinical Milestones Anticipated for All Three Development Compounds Lead Compound OBE2109 Endometriosis Phase [...]